BenzingaDoubao · 实盘不做把握 8/10不做原因:无增量信息
北京时间·🕒 发布 19:55:06·⟳ 抓取 19:55:20 +14s·⚡ 决策 10-19 19:56:41 +1m21s·8.0 天前
Benzinga 前瞻 Danaher(Q3财报10月21日盘前公布)，罗列一致预期与10月初以来分析师目标价，无新增事实
本文是媒体在财报前两天发布的前瞻/流量稿，全部内容(一致 EPS/营收预期、10月初以来的目标价调整、10月14日 NVIDIA 合作)均已公开，无盈利意外、无指引修正、无新订单或新事实；在实际财报(10月21日盘前)落地前不存在方向性 edge，属典型无新增信息事件。
📄 原文Benzinga↗ 原文
Danaher Corporation (NYSE:DHR) will release earnings for its third quarter before the opening bell on Wednesday, Oct. 2…
不做 Danaher Corporation（DHR.US）
无新增事实的财报前瞻/分析师评级汇总：一致预期(EPS $1.92、营收 $6.56B)、目标价调整(10/1-10/13)与 NVIDIA 合作(10/14)均已公开且大概率 price-in；真正催化在10月21日盘前财报，当前提前押注无 edge，等财报实际数据与指引发布后再研判。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
这是 Danaher Q3 财报(10/21盘前)前的分析师预期与目标价汇编稿，无新增基本面事实或意外；真正催化尚未发生，当前不构成可交易机会，故回避。
🔎 新鲜度:最早出现 2026-10-19 · 扩散 high · price-in 风险 high ↗
关键理由
- 无可支撑开仓的新增利多或利空：一致预期与评级调整均为存量公开信息，业绩本身要到10月21日盘前才公布。
主要风险
- 财报当周(10/21盘前)实际 EPS/营收及核心生物工艺业务指引相对一致预期的偏离，才是真正波动来源，需待财报发布后单独研判，不应以本前瞻稿提前押注。
先例如何影响了这次决策
对本次决策的影响:确认不交易：缺乏新增信息，先例检索不会把一篇预期汇编稿变成有 edge 的催化。
方向:无真实同类一手先例可用于校准；且本文为无新增事实的财报前瞻，不属于需要先例定价的催化事件，故不展开 event_study。
涨幅量级:无可比幅度；真正的财报日(10/21)反应需在财报发布后以实际惊喜为锚另行研究。
形态:不适用
工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 11 ms
{"result": "search_processed_events:agent query=`danaher dhr q3 2026 earnings preview analyst price target revisions | danaher nvidia autonomous science ai collaboration october 14 2026 | danaher third quarter earnings october 21`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 0.0/72 小时、0 条本臂决策(完整)，返回 0 条候选。未命中只表示这些 agen
原文全文
展开原文 · 1,933 字
Danaher Corporation (NYSE:DHR) will release earnings for its third quarter before the opening bell on Wednesday, Oct. 21.
Analysts expect the company to report quarterly earnings of $1.92 per share, up from $1.89 per share in the year-ago period. The consensus estimate for DHR’s quarterly revenue is $6.56 billion. It reported $6.05 billion last year, according to Benzinga Pro.
On Oct. 14, Danaher announced an AI collaboration with NVIDIA Corp (NASDAQ:NVDA) focused on autonomous science.
Danaher shares fell 1.1% to close at $229.04 on Friday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
- TD Cowen analyst Dan Brennan maintained a Buy rating and raised the price target from $236 to $255 on Oct. 13, 2026. This analyst has an accuracy rate of 73%.
- Barclays analyst Luke Sergott maintained an Overweight rating and boosted the price target from $230 to $255 on Oct. 7, 2026. This analyst has an accuracy rate of 69%.
- RBC Capital analyst Dan Leonard maintained an Outperform rating and raised the price target from $215 to $250 on Oct. 5, 2026. This analyst has an accuracy rate of 70%.
- Guggenheim analyst Subbu Nambi maintained the stock with a Buy rating and increased the price target from $200 to $250 on Oct. 1, 2026. This analyst has an accuracy rate of 78%.
- Wells Fargo analyst Brandon Couillard maintained an Equal-Weight rating and cut the price target from $212 to $195 on July 22, 2026. This analyst has an accuracy rate of 74%.
Considering buying DHR stock? Here’s what analysts think:
Photo via Shutterstock
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
Analysts expect the company to report quarterly earnings of $1.92 per share, up from $1.89 per share in the year-ago period. The consensus estimate for DHR’s quarterly revenue is $6.56 billion. It reported $6.05 billion last year, according to Benzinga Pro.
On Oct. 14, Danaher announced an AI collaboration with NVIDIA Corp (NASDAQ:NVDA) focused on autonomous science.
Danaher shares fell 1.1% to close at $229.04 on Friday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
- TD Cowen analyst Dan Brennan maintained a Buy rating and raised the price target from $236 to $255 on Oct. 13, 2026. This analyst has an accuracy rate of 73%.
- Barclays analyst Luke Sergott maintained an Overweight rating and boosted the price target from $230 to $255 on Oct. 7, 2026. This analyst has an accuracy rate of 69%.
- RBC Capital analyst Dan Leonard maintained an Outperform rating and raised the price target from $215 to $250 on Oct. 5, 2026. This analyst has an accuracy rate of 70%.
- Guggenheim analyst Subbu Nambi maintained the stock with a Buy rating and increased the price target from $200 to $250 on Oct. 1, 2026. This analyst has an accuracy rate of 78%.
- Wells Fargo analyst Brandon Couillard maintained an Equal-Weight rating and cut the price target from $212 to $195 on July 22, 2026. This analyst has an accuracy rate of 74%.
Considering buying DHR stock? Here’s what analysts think:
Photo via Shutterstock
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
9f807f71ab· 2026-10-19 19:56 · doubao / doubao-seed-evolving-latest-version · 策略包658c0c1e2ba5当前